US: Medical devices and leads transfer pricing issues | KPMG | US

Tax Court: Medical devices and leads, transfer pricing issues

US: Medical devices and leads transfer pricing issues

The U.S. Tax Court today released a 144-page memorandum opinion concerning the treatment of income from intercompany licenses for intangible property required to manufacture certain medical devices and leads.


Related content

The IRS determined deficiencies in the taxpayer’s federal income tax exceeding $548 million for 2005 and $810 million for 2006.

At issue was whether the income related to the intercompany licenses needed to be reallocated under section 482 to the U.S. company from its subsidiary in Puerto Rico, and whether a related party in Europe made arm’s length payments to the U.S. entity or accrued royalties in excess of arm’s length to manufacture devices sold to another U.S. entity pursuant to a supply agreement. Another question posed was whether, alternatively, the taxpayer and related entities transferred intangible property compensable under section 367(d) when the U.S. entity restructured its Puerto Rican operations.

The case is: Medtronic, Inc. v. Commissioner, T.C. Memo. 2016-112 (June 9, 2016)

The purpose of this report is to provide text of the 144-page opinion. Read the Tax Court’s memorandum opinion [PDF 466 KB]

© 2018 KPMG LLP, a Delaware limited liability partnership and the U.S. member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. All rights reserved.

The KPMG logo and name are trademarks of KPMG International. KPMG International is a Swiss cooperative that serves as a coordinating entity for a network of independent member firms. KPMG International provides no audit or other client services. Such services are provided solely by member firms in their respective geographic areas. KPMG International and its member firms are legally distinct and separate entities. They are not and nothing contained herein shall be construed to place these entities in the relationship of parents, subsidiaries, agents, partners, or joint venturers. No member firm has any authority (actual, apparent, implied or otherwise) to obligate or bind KPMG International or any member firm in any manner whatsoever. The information contained in herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 4366, 1801 K Street NW, Washington, DC 20006.

Connect with us


Request for proposal